TJ
Taubert Jennifer L
Directrice Exécutive
OtherF
Insider track record
ExecutiveNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Taubert Jennifer L, Directrice Exécutive. Officer active across 1 company, notably Johnson & Johnson. Aggregated, 14 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €3.4m. History available since 14 February 2022. The latest transaction was disclosed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Taubert Jennifer L
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
15,000 shares@ US$115.670.0003% mcap6.2% of flowCommon StockSEC:0000200406-26-000175:0
15,000 shares@ US$263.360.0006% mcap14.0% of flowCommon StockSEC:0000200406-26-000175:1
1,302 shares0Common StockSEC:0000200406-26-000037:0
56,471 shares@ US$101.8730.8% of flowCommon StockSEC:0000200406-25-000186:0
1,302 shares0Common StockSEC:0000200406-25-000052:0
58,504 shares@ US$100.0650.9% of flowCommon StockSEC:0000200406-25-000013:0
1,302 shares0Common StockSEC:0001225208-24-002181:0
22,433 shares0Common StockSEC:0001225208-24-002103:0
3,739 shares0Common StockSEC:0001225208-24-001900:0
21,422 shares0Common StockSEC:0001225208-23-002065:0
3,570 shares0Common StockSEC:0001225208-23-001907:0
76,923 shares@ US$72.5449.1% of flowCommon StockSEC:0001225208-22-011890:0
18,064 shares0Common StockSEC:0001225208-22-002377:0
3,297 shares0Common StockSEC:0001225208-22-002211:0
About Taubert Jennifer L
Taubert Jennifer L is Directrice Exécutive and EVP, WWC. Innovative Medicine at Johnson & Johnson (XNAS). She has 12 filings in total, and across the 12 sampled filings the buy and sell amounts are both EUR 0, over the period from 2022-02-15 to 2026-02-18. The most frequent transaction nature is option exercise.